drugset / Trial / NCT00760474

An fMRI Study Of Brain Response In Patients With Fibromyalgia

NCT00760474

Phase 1 Completed 27 enrolled Viatris Inc.
RandomizedCrossoverQuadruple-blindOther

Summary

The purpose of this study is to explore how pregabalin works in patients with fibromyalgia by evaluating brain imaging signals. To find out whether fMRI (functional magnetic resonance imaging) is an efficient way to show whether new pain medications are effective in treating fibromyalgia.

Timeline

Start
2009-01
Primary completion
2011-03
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 450 mg Oral

Indications